National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

monoclonal antibody KW-2871
A low-fucose, human-mouse chimeric IgG1 monoclonal antibody directed against the ganglioside GD3, a surface antigen expressed on many malignant melanoma cells, with potential antineoplastic activity. Monoclonal antibody KW-2871 binds to GD3-positive cells, thereby initiating antibody-dependent cytotoxicity against GD3-positive cells. This agent is prepared by fusing murine immunoglobulin (Ig) light and heavy variable regions derived from the murine IgG3 antibody KM-641 to a human constant (Fc) region. The low fucose content of the oligosaccharide side chains of this antibody may enhance binding of the antibody Fc region to lymphocyte Fc receptors. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:monoclonal antibody Hu3S193, monoclonal antibody HuAFP31, monoclonal antibody HuHMFG1, monoclonal antibody HuM291, monoclonal antibody HuPAM4
Next:monoclonal antibody L6, monoclonal antibody Lym-1, monoclonal antibody m170, monoclonal antibody MDX-060, monoclonal antibody Me1-14 F(ab')2

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov